Vontobel Holding’s Medifast MED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
– Sell
-4,067
Closed -$441K – 1107
2022
Q3
$441K Hold
4,067
– – 0.01% 749
2022
Q2
$744K Buy
4,067
+693
+21% +$124K 0.01% 615
2022
Q1
$577K Buy
+3,374
New +$636K 0.01% 750
2021
Q4
– Sell
-2,000
Closed -$385K – 1160
2021
Q3
$385K Buy
2,000
+1,000
+100% +$246K ﹤0.01% 872
2021
Q2
$283K Sell
1,000
-900
-47% -$244K ﹤0.01% 934
2021
Q1
$402K Buy
1,900
+400
+27% +$95.7K ﹤0.01% 722
2020
Q4
$295K Buy
+1,500
New +$265K ﹤0.01% 802

Other funds holding MED

Vontobel Holding's MED Position: Q4 2022 in Review

Vontobel Holding sold out of Medifast (MED) in Q4 2022, closing a stake of 4,067 shares — an estimated $441K sold.

Vontobel Holding first reported a position in MED in Q4 2020 and held it in 7 quarters. The position peaked at $744K in Q2 2022. 277 funds tracked by Wall St. Rank hold MED as of Q4 2022.

  • Vontobel Holding reported no remaining Medifast position as of Q4 2022 after selling out during the quarter.
  • Vontobel Holding sold 4,067 Medifast shares in Q4 2022, an estimated $441K.
  • Vontobel Holding first reported a position in Medifast in Q4 2020 and held it in 7 quarters.
  • Vontobel Holding's Medifast position peaked at $744K in Q2 2022.
  • 277 funds tracked by Wall St. Rank held Medifast as of Q4 2022.

Based on Vontobel Holding's 13F filing for Q4 2022, filed 14 Feb 2023.